C12N 2795/10161
Methods of inactivation or attenuation
C12N2795/10161 (Methods of inactivation or attenuation) appears on 9 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 6
- Assignees
- 7
- Inventors
- 19
- Latest grant
- 17 Jul 2007
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 1 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Template reporter bacteriophage platform and multiple bacterial detection assays based thereon17 Jul 2007US 7,244,612 B2University of Wyoming
- Lysin-deficient bacteriophages having reduced immunogenicity8 Aug 2006US 7,087,226 B2GangaGen, Inc.
- Lysin-deficient bacteriophages having reduced immunogenicity24 May 2005US 6,896,882 B2GangaGen, Inc.
- Methods and compositions for the selective modification of nucleic acids9 Sep 2003US 6,617,157 B1V. I. Technologies, Inc.
- Inviable virus particles as scaffolds for constructing flexible detection systems31 Dec 2002US 6,500,611 B2
- Continuous Multiplexed Phage Genome Engineering Using a Retron Editing Template17 Jul 2025US 2025/0230429 A1The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Glads
- Template reporter bacteriophage platform and multiple bacterial detection assays based thereon21 Sep 2006US 2006/0210968 A1University of Wyoming
- Lysin-deficient bacteriophages having reduced immunogenicity13 Oct 2005US 2005/0226851 A1GangaGen, Inc.
- Methods and compositions for the selective modification of nucleic acids18 Mar 2004US 2004/0053316 A1V. I. Technologies, Inc.
- Lysin-deficient bacteriophages having reduced immunogenicity26 Jun 2003US 2003/0118558 A1GangaGen, Inc.
Most cited
By later US patents
- Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer42US 5,798,238 ABaxter International Inc. · 1998
- Method of inactivation of viral and bacterial blood contaminants25US 5,955,256 ABaxter International Inc. · 1999
- Methods and compositions for the selective modification of nucleic acids24US 6,093,564 AV. I. Technologies, Inc. · 2000
- Lysin-deficient bacteriophages having reduced immunogenicity23US 7,087,226 B2GangaGen, Inc. · 2006
- Template reporter bacteriophage platform and multiple bacterial detection assays based thereon22US 7,244,612 B2University of Wyoming · 2007